Anika Therapeutics, Inc.
US ˙ NasdaqGS ˙ US0352551081

SecurityANIK / Anika Therapeutics, Inc.
InstitutionUbs Ag
Latest Disclosed Ownership39,231 shares
Latest Disclosed Value $ 1,438,000
Ubs Ag ownership in ANIK / Anika Therapeutics, Inc.

On November 12, 2014 - Ubs Ag filed a 13F-HR form disclosing ownership of 39,231 shares of Anika Therapeutics, Inc. (US:ANIK) valued at $1,438,208 USD as of September 30, 2014. The entity filed a previous 13F-HR on August 14, 2014 disclosing 47,044 shares of Anika Therapeutics, Inc.. This represents a change in shares of -16.61% during the quarter. The current value of the position is $565,319 USD.

Ubs Ag has a history of taking positions in derivatives of the underlying security (ANIK) in the form of stock options. The firm currently holds call options representing 3,000 of underlying shares valued at $110,000 USD and put options representing 200 of underlying shares valued at $7,000 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

ANIK / Anika Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2014-11-12 2014-09-30 13F ANIKA THERAPEUTICS COM 035255108 39,231 -7,813 -16.61 1,438 -34.04 0.0011
2014-08-14 2014-06-30 13F ANIKA THERAPEUTICS COM 035255108 47,044 31,665 205.90 2,180 244.94 0.0017
2014-05-16 2014-03-31 13F/A-1 ANIKA THERAPEUTICS COM 035255108 15,379 11,576 304.39 632 335.86 0.0006
2014-05-15 2014-03-31 13F ANIKA THERAPEUTICS COM 035255108 15,379 632
2014-05-21 2013-12-31 13F/A-1 ANIKA THERAPEUTICS COM 035255108 3,803 2,643 227.84 145 417.86 0.0001
2014-02-14 2013-12-31 13F ANIKA THERAPEUTICS COM 035255108 3,803 145
2013-11-13 2013-09-30 13F ANIKA THERAPEUTICS COM 035255108 1,160 800 222.22 28 366.67 0.0000
2013-08-14 2013-06-30 13F ANIKA THERAPEUTICS COM 035255108 360 360 6 0.0000
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2014-11-12 2014-09-30 13F ANIKA THERAPEUTICS COM Call 3,000 -3.23 110 -23.61 n/a n/a n/a
2014-08-14 2014-06-30 13F ANIKA THERAPEUTICS COM Call 3,100 158.33 144 193.88 n/a n/a n/a
2014-05-16 2014-03-31 13F/A ANIKA THERAPEUTICS COM Call 1,200 1,100.00 49 1,125.00 n/a n/a n/a
2014-05-15 2014-03-31 13F ANIKA THERAPEUTICS COM Call 1,200 49 n/a n/a n/a
2014-05-21 2013-12-31 13F/A ANIKA THERAPEUTICS COM Call 100 4 n/a n/a n/a
2014-02-14 2013-12-31 13F ANIKA THERAPEUTICS COM Call 100 4 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2014-11-12 2014-09-30 13F ANIKA THERAPEUTICS COM Put 200 -81.82 7 -86.27 n/a n/a n/a
2014-08-14 2014-06-30 13F ANIKA THERAPEUTICS COM Put 1,100 -69.44 51 -65.54 n/a n/a n/a
2014-05-16 2014-03-31 13F/A ANIKA THERAPEUTICS COM Put 3,600 148 n/a n/a n/a
2014-05-15 2014-03-31 13F ANIKA THERAPEUTICS COM Put 3,600 148 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.